Genavli Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.35 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -338.40%
- Ebitda -742.52%
- Net Worth -115.13%
- Total Assets 239.40%
About Genavli Biotech
Genavli Biotech Private Limited (GBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 December 2017 (Seven years and one month 8 days old ). Its registered office is in Solapur, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.35 M, as per Ministry of Corporate Affairs (MCA) records.
Gurunath Wachche, Avinash Abhyankar, and Suresh Rathod serve as directors at the Company.
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100PN2017PTC173966
- Company No.
173966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Genavli Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurunath Wachche  | Director | 21-Dec-2017 | Current |
Avinash Abhyankar  | Director | 18-May-2019 | Current |
| Suresh Rathod | Director | 22-Jun-2021 | Current |
Financial Performance of Genavli Biotech.
Genavli Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 338.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 115.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genavli Biotech?
Unlock access to Genavli Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Genavli Lifesciences Private LimitedGurunath Wachche, Avinash Abhyankar and 1 more are mutual person
- Medavenue Education And Health Solutions Private Limited
Suresh Rathod is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genavli Biotech?
Unlock and access historical data on people associated with Genavli Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genavli Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genavli Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
